Deepa Venkataraman Email & Phone Number

California, United States

Redwood City, California, Us

Responsible for Global Patient Safety and Pharmacovigilance of Corcept's development compounds and marketed product. Reporting to the Chief Business Officer.About Corcept- Pioneering the discovery and development of Cortisol Modulators in the areas of Endocrinology, Oncology, Neurology, Hepatology, Psychiatry and beyond.

Miami, Florida, Us

As the Head of QA, responsible for R&D QA, Quality Systems, GMP QA, reporting to COO and CEO.As the Head of Patient Safety and PV, responsible for all aspects of patient safety- Safety Operations, Safety Sciences, Medical Review, Risk Management, Safety Compliance, Safety Systems.

Miami, Florida, Us

Responsible for all aspects of patient safety- Safety Operations, Safety Sciences, Medical Review, Risk Management, Safety Compliance, Safety Systems. Reporting to COO.

North Chicago, Illinois, Us

Responsible for Global Case Management, Medical Coding and Medical Safety Review functions for Legacy Allergan business, with teams (100+ staff) located in Romania, New Jersey, California.My team comprised of Physicians, Pharmacists, Nurses, other HCPs/Life Sciences graduates.

North Chicago, Illinois, Us

Sunnyvale, Ca, Us

I was responsible for the following functions: Clinical Trial and Postmarketing Case Management, Medical Review, Vendor and Alliance Management, Study Management, PV Quality, Standards and Training, Project Management and Safety Systems.My team was located in California, remote-US and India, total of ~100 staff, comprised of Physicians, Pharmacists, Nurses, other HCPs/Life Sciences graduates.

Sunnyvale, Ca, Us

Lead Pharmacovigilance function at Pharmacyclics. Responsible for clinical trial and postmarketing activities, alliances and vendor management, quality and compliance.

Sunnyvale, Ca, Us

Responsible for clinical trial and postmarketing case management, alliances and vendor management.

Sunnyvale, Ca, Us

• Oversee drug safety operations including all case management activities in both clinical and post marketing settings. • Contribute to a full range of pharmacovigilance (PV) activities for investigational product and marketed products, including cross functional operational activities, process improvement initiatives, quality systems, audits and inspections.

Sunnyvale, Ca, Us

Managed a team of clinical drug safety specialists and consultants, overseeing all case processing activities and drug safety operations. Coordinated safety operations across two alliance partners and six clinical vendors/CROs, including external investigators’ safety reporting. Led the setup of new safety projects, developing and updating Safety Management Plans while implementing departmental safety policies and SOPs. Participated in GCP/GMP inspections and contributed to safety data analysis for clinical studies. Provided expert regulatory guidance and represented safety in clinical meetings, ensuring effective communication and compliance.

New Brunswick, Nj, Us

Led multiple Phase 1-4 compound projects, overseeing protocol reviews, trial reconciliations, and Safety Management Plans. Coordinated product transitions across sites as the primary contact for operational issues. Served as a Subject Matter Expert in clinical trials and conducted compliance analyses for vendor and regulatory standards. Developed company SOPs in line with new EU legislation and trained new hires while mentoring team members. Promoted in April 2012, receiving three awards for innovation and strategic thinking.

Durham, North Carolina, Us

Led a team of 20 pharmacovigilance specialists managing hundreds of adverse event reports weekly across global clinical safety and post-marketing projects. Monitored project finances and provided regular status updates to senior management, ensuring alignment with budgets and project scope. Handled adverse event and serious adverse event reports for regulatory submissions, adhering to applicable regulations and standard operating procedures. Served as a Subject Matter Expert on product quality complaints and regulatory compliance, contributing to data collection for pharmacovigilance plans and aggregate reports. Recognized for my contributions with three promotions and 15 awards during my tenure, while also serving as a certified trainer for new hires.

I synthesized 15 novel thiazine derivatives, all of which were characterized using UV, IR, NMR, and mass spectrometry techniques. The antibacterial activity of these compounds was evaluated through in vitro methods. Following ethics committee approval, in vivo studies were conducted on Swiss Albino mice to assess their anticonvulsant activities.

Key Areas: Pharmacology, Pharmacognosy, Forensic Pharmacy and Pharma Medicinal Chemistry

Development of enhanced formulations to effectively increase the quality and organoleptic properties of syrups.I had monitored this entire project and had successfully seen it through completion.

Product development to mask bitter liquid formulationsI had synthesized two new products to effectively mask the bitter tastes of liquid formulations mainly cough syrups.

Medical Aspects Of Adverse Drug Reactions

Research Methods And Biostatistics

M.Pharm, M.S, Pharma Medicinal Chemistry

Modern Instrumental Techniques (Hplc, Gc, Gc-Ms, Ftir, Uv-Vis)

B. Pharm, B.S, Pharmacy